BPC-157 vs TB-500: A Research Comparison
All information here is for laboratory and educational research only. No compound referenced is approved for human or veterinary use, and nothing here is medical advice.
- BPC-157 and TB-500 are two lab-made peptides (short chains of amino acids, the building blocks of proteins) that researchers study in tissue-repair experiments. They are different compounds with different origins and are studied for different cell pathways, but they come up together in healing research.
- In published studies, BPC-157 has been looked at for forming new blood vessels and for tendon, ligament, and muscle repair, while TB-500 has been looked at for cell movement and inflammation. Researchers guess the two might work in complementary ways, but that pairing is exploratory, not a proven combination.
- The evidence is thin and early. Most BPC-157 work is in small rodent studies and its effect has not been confirmed in people. TB-500's parent protein has reached some early human study for skin, but TB-500 itself is still a research compound. Sample sizes are small and few groups have published.
- Online and community reports of people pairing the two are personal impressions, not controlled findings. TB-500 also appears on the World Anti-Doping Agency banned list, and U.S. regulators have flagged BPC-157 over compounding concerns.
- Neither compound is approved for human or veterinary use, and nothing here is medical advice. BioRegen sells these strictly as materials for laboratory and educational research only, and makes no claim that they work.
BPC-157 and TB-500 are two peptides that scientists study a lot when they look at how the body repairs tissue. (TB-500 is a lab-made piece of a natural protein called thymosin beta-4.) Researchers often talk about the two together. All information here is for laboratory and educational research only. No compound referenced is approved for human or veterinary use, and nothing here is medical advice. This article explains what each one is, what researchers are looking at in the lab, and how far along the research is, so lab readers can see how the two differ.
What BPC-157 and TB-500 are
BPC-157 is a small lab-made peptide built from 15 amino acids (the building blocks of proteins). Its sequence was first spotted in stomach fluid, and in research papers it is often called a "body protection compound." TB-500 is a lab-made peptide that copies an active part of thymosin beta-4, a natural protein found in platelets and many kinds of cells. Both are used as research materials in early studies of tissue repair, the kind done in cells and animals before any human testing. Neither is an approved drug. For a wider look at how researchers sort peptides like these, see our research finder.
Mechanisms researchers explore
In published studies, BPC-157 has been looked at for a few things: how it may relate to the growth of new blood vessels (called angiogenesis), how it may change the levels of certain growth signals in cells, and how it affects the healing of tendons, ligaments, and muscle in rats and mice. TB-500, as a piece of thymosin beta-4, has mostly been studied for how it binds to a cell building-block called actin, how it helps cells move, how it relates to new blood-vessel growth, and how it may calm inflammation. Researchers sometimes talk about the two together because they think the two might work in ways that complement each other: one is studied more for blood vessels and growth signals, the other more for cell structure and cell movement. Any mention of pairing them in the research is still just an early idea, not a tested combination.
Side-by-side at a glance
| What to compare | BPC-157 | TB-500 |
|---|---|---|
| Where it comes from | Lab-made; 15-amino-acid sequence first found in stomach fluid | Lab-made copy of a piece of thymosin beta-4 |
| What researchers study | New blood-vessel growth, growth-signal levels | Binding to actin, cell movement, new blood-vessel growth |
| Most common research focus | Tendon, ligament, and muscle studies | Skin and broader tissue-repair studies |
| How far along the research is | Mostly early studies in animals | Some early human studies of the parent protein |
Research stage and limitations
Most BPC-157 studies have been done in rats and mice, and it has not been shown to work in people. The parent protein of TB-500, thymosin beta-4, has moved into some early human studies for skin-related uses, but TB-500 itself is still a research compound. For both, the studies are small, they are run in different ways, and only a few research groups have published detailed work. Online forums and personal stories about pairing the two are common, but these are just anecdotes, not controlled studies, and BioRegen does not make or back any claims based on them. If you are comparing recovery-related research peptides, our comparison of metabolic research peptides can show how research stages differ from one group of compounds to another.
Handling notes for the laboratory
Both usually come as a freeze-dried powder for lab use. Common good-practice tips from the research include keeping the dry powder cold, mixing it back into liquid with a suitable sterile fluid in the lab, and avoiding repeated freezing and thawing so the peptide stays intact. For a general walkthrough of how researchers mix a powder back into liquid in the lab, see our guide on how to reconstitute peptides. These notes are about handling research materials only and are not directions for use in people or animals.
Are BPC-157 and TB-500 the same thing?
No. They are two different peptides. They come from different sources and researchers study them for different reasons, even though both show up in tissue-repair research.
Why are they often discussed together?
Researchers think the things each one is studied for may work well side by side. One is studied more for blood vessels and growth signals, the other more for cell structure and cell movement. This is still an early idea being explored, not a proven combination.
Has either been approved for human use?
No. Neither one is approved for use in people or animals. Both are studied only as research materials.
Selected research references
- Gwyer D, Wragg NM, Wilson SL. Gastric pentadecapeptide body protection compound BPC 157 and its role in accelerating musculoskeletal soft tissue healing. Cell Tissue Res. 2019. https://doi.org/10.1007/s00441-019-03016-8
- Seiwerth S, et al. Stable Gastric Pentadecapeptide BPC 157 and Wound Healing. Front Pharmacol. 2021. https://doi.org/10.3389/fphar.2021.627533
- Kleinman HK, Sosne G. Thymosin β4 Promotes Dermal Healing. Vitam Horm. 2016. https://doi.org/10.1016/bs.vh.2016.04.005
Reference metadata sourced via PubMed.
Continue your laboratory research with our research guide, and create a free account for 10% off your first order. Explore the related research-grade peptides in our Regenesis research category.
All information on this page is provided strictly for laboratory and educational research purposes. No compound referenced is approved for human or veterinary use, and nothing here constitutes medical advice. Statements describe published or exploratory research and are not claims that any compound treats, cures, or prevents any condition.